Geneos Wealth Management’s Aptus Defined Risk ETF DRSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-179
Closed -$4.84K 2571
2024
Q2
$4.84K Sell
179
-112
-38% -$2.97K ﹤0.01% 1729
2024
Q1
$7.76K Hold
291
﹤0.01% 1603
2023
Q4
$7.33K Sell
291
-23,324
-99% -$558K ﹤0.01% 1629
2023
Q3
$550K Sell
23,615
-6,179
-21% -$152K 0.03% 450
2023
Q2
$741K Sell
29,794
-1,523
-5% -$38.6K 0.04% 375
2023
Q1
$813K Sell
31,317
-3,085
-9% -$79.7K 0.05% 337
2022
Q4
$881K Sell
34,402
-3,496
-9% -$89.7K 0.05% 297
2022
Q3
$962K Buy
37,898
+1,548
+4% +$41.1K 0.07% 260
2022
Q2
$962K Sell
36,350
-215
-0.6% -$5.79K 0.05% 332
2022
Q1
$1.02M Buy
+36,565
New +$1.03M 0.04% 347
2021
Q2
Sell
-13,950
Closed -$409K 2908
2021
Q1
$409K Sell
13,950
-3,836
-22% -$113K 0.01% 685
2020
Q4
$34K Buy
+17,786
New +$536K ﹤0.01% 1641

Other funds holding DRSK

Geneos Wealth Management's DRSK Position: Q3 2024 in Review

Geneos Wealth Management sold out of Aptus Defined Risk ETF (DRSK) in Q3 2024, closing a stake of 179 shares — an estimated $4.84K sold.

Geneos Wealth Management first reported a position in DRSK in Q4 2020 and held it in 12 quarters. The position peaked at $1.02M in Q1 2022. 67 funds tracked by Wall St. Rank hold DRSK as of Q3 2024.

  • Geneos Wealth Management reported no remaining Aptus Defined Risk ETF position as of Q3 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 179 Aptus Defined Risk ETF shares in Q3 2024, an estimated $4.84K.
  • Geneos Wealth Management first reported a position in Aptus Defined Risk ETF in Q4 2020 and held it in 12 quarters.
  • Geneos Wealth Management's Aptus Defined Risk ETF position peaked at $1.02M in Q1 2022.
  • 67 funds tracked by Wall St. Rank held Aptus Defined Risk ETF as of Q3 2024.

Based on Geneos Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.